Home/Kivu Bioscience/Sophia Randolph, MD, PhD
SR

Sophia Randolph, MD, PhD

Chief Medical Officer

Kivu Bioscience

Therapeutic Areas

Kivu Bioscience Pipeline

DrugIndicationPhase
KIVU-107Solid tumorsIND-Enabling
KIVU-305Solid tumorsIND-Enabling
KIVU-495Solid tumorsIND-Enabling
KIVU-202Solid tumorsDevelopment Candidate